Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tenecteplase: a review.

L Davydov1, J W Cheng

  • 1Mount Sinai Medical Center, New York, NY 10029, USA.

Clinical Therapeutics
|August 25, 2001
PubMed
Summary
This summary is machine-generated.

Tenecteplase offers a convenient single-bolus administration for acute myocardial infarction. This fibrin-specific thrombolytic agent demonstrates equivalent efficacy and tolerability to alteplase, with improved safety profiles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Investigation and analysis of underground noise in Sichuan coal mines].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2022
Same author

[Association between a novel regulatory genetic variants and lung cancer risk in Chinese: a two-stage case-control study].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2021
Same author

[Study on the value of serum des-γ-carboxy prothrombin in predicting hepatocellular carcinoma recurrence after liver transplantation].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2020
Same author

[Focus on the controversial problems of orbital decompression in the treatment of dysthyroid optic neuropathy].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2018
Same author

Synthesis, dual-nonlinear magnetic resonance and microwave absorption properties of nanosheet hierarchical cobalt particles.

Physical chemistry chemical physics : PCCP·2014
Same author

Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.

Journal of clinical pharmacy and therapeutics·2014
Same journal

Early Feasibility Studies in Europe: A Multisite Qualitative Study of Operational Challenges and Site Selection Determinants at 6 University Hospitals.

Clinical therapeutics·2026
Same journal

Safety of Celecoxib in Elderly Patients With Osteoarthritis: A Real-World Analysis Based on the FAERS Database.

Clinical therapeutics·2026
Same journal

Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

Clinical therapeutics·2026
Same journal

Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

Clinical therapeutics·2026
Same journal

Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

Clinical therapeutics·2026
Same journal

Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

Clinical therapeutics·2026
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Existing thrombolytic agents have limitations, driving the need for agents with improved fibrin specificity and longer half-lives.
  • Such properties could enable bolus administration for faster arterial reperfusion.

Purpose of the Study:

  • To review the novel thrombolytic agent tenecteplase.
  • Focus on its mechanism, pharmacokinetics, efficacy, tolerability, and drug interactions in acute myocardial infarction management.

Main Methods:

  • Literature search of MEDLINE, EMBASE, and International Pharmaceutical Abstracts (1966-2001).
  • Search terms included tenecteplase, myocardial infarction, TNK, and TNK-tPA.
  • Inclusion of recent conference abstracts.

Main Results:

Related Experiment Videos

  • Tenecteplase, a modified tissue-type plasminogen activator (tPA), exhibits 14-fold greater fibrin specificity and an 18-minute half-life, allowing single-bolus administration.
  • Clinical trials show tenecteplase has equivalent efficacy to alteplase but with a similar rate of intracranial hemorrhage.
  • Tenecteplase use was associated with fewer noncerebral complications and reduced need for blood transfusions.

Conclusions:

  • Tenecteplase is as effective and well-tolerated as alteplase for acute myocardial infarction.
  • Its single-bolus administration offers enhanced convenience.